Considerations on combination therapies for disease modification in Parkinson’s

Rachel M. Hughes, Aleksandra Pilcicka, Trevor Klee, Fiona Ducotterd, Heather Mortiboys, Simon R. W. Stott

Open source

DOI
10.1038/s41531-026-01483-9
Published
2026-07-17
Container
npj Parkinson's Disease
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41531-026-01483-9,
  title = {Considerations on combination therapies for disease modification in Parkinson’s},
  author = {Rachel M. Hughes and Aleksandra Pilcicka and Trevor Klee and Fiona Ducotterd and Heather Mortiboys and Simon R. W. Stott},
  year = {2026},
  journal = {npj Parkinson's Disease},
  doi = {10.1038/s41531-026-01483-9},
  url = {https://doi.org/10.1038/s41531-026-01483-9}
}

RIS

TY  - JOUR
TI  - Considerations on combination therapies for disease modification in Parkinson’s
AU  - Rachel M. Hughes
AU  - Aleksandra Pilcicka
AU  - Trevor Klee
AU  - Fiona Ducotterd
AU  - Heather Mortiboys
AU  - Simon R. W. Stott
PY  - 2026
JO  - npj Parkinson's Disease
DO  - 10.1038/s41531-026-01483-9
UR  - https://doi.org/10.1038/s41531-026-01483-9
ER  - 

APA

Hughes, R. M., Pilcicka, A., Klee, T., Ducotterd, F., Mortiboys, H., & Stott, S. R. W. (2026). Considerations on combination therapies for disease modification in Parkinson’s. npj Parkinson's Disease. https://doi.org/10.1038/s41531-026-01483-9

Source records